The store will not work correctly when cookies are disabled.
Isopropyl-carbamic acid 5,10-dioxo-5,10-dihydro-benzo[g]quinolin-3-ylmethyl ester
ID: ALA171843
PubChem CID: 44385112
Max Phase: Preclinical
Molecular Formula: C18H16N2O4
Molecular Weight: 324.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)NC(=O)OCc1cnc2c(c1)C(=O)c1ccccc1C2=O
Standard InChI: InChI=1S/C18H16N2O4/c1-10(2)20-18(23)24-9-11-7-14-15(19-8-11)17(22)13-6-4-3-5-12(13)16(14)21/h3-8,10H,9H2,1-2H3,(H,20,23)
Standard InChI Key: JMGCRFRACCEYBT-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
3.7042 -0.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7042 0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 -0.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 0.9208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2542 -0.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2667 0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4167 0.9125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5667 -1.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4167 -0.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2792 -1.5625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 -1.5667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 1.7458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1375 -0.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5667 -2.8042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8542 -1.5667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1292 0.5083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8542 -0.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5500 0.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5500 -0.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9917 -1.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0000 -2.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7125 -1.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8375 0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8375 -0.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 2 1 0
5 3 1 0
6 5 2 0
7 2 1 0
8 15 1 0
9 1 1 0
10 8 1 0
11 3 2 0
12 4 2 0
13 9 2 0
14 8 2 0
15 17 1 0
16 13 1 0
17 13 1 0
18 6 1 0
19 5 1 0
20 10 1 0
21 20 1 0
22 20 1 0
23 24 1 0
24 19 2 0
7 16 2 0
6 4 1 0
18 23 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 324.34 | Molecular Weight (Monoisotopic): 324.1110 | AlogP: 2.49 | #Rotatable Bonds: 3 |
Polar Surface Area: 85.36 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.96 | CX LogP: 2.42 | CX LogD: 2.42 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.80 | Np Likeness Score: -0.11 |
References
1. Lee H, Hong S, Kim Y. (1996) Synthesis and in vitro evaluation of 3-substituted-1-azaanthraquinones, 6 (8): [10.1016/0960-894X(96)00156-4] |